SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Accentia Biopharmaceuticals, Inc
An SI Board Since January 2008
Posts SubjectMarks Bans Symbol
8 2 0 ABPI
Emcee:  John McCarthy Type:  Unmoderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
8Here is the Biovest CC from yesterday. vcall.com Looks like they picked up thekenhott-7/22/2008
7Biovest Reports Results for Patients Treated with Anti-Cancer Vaccine: BiovaxID(kenhott-7/21/2008
6from seeking alpha: On Tuesday, Accentia Biopharmaceuticals (ABPI) reported thmopgcw-6/19/2008
5Complete molecular remissions induced by patient-specific vaccination plus granuJohn McCarthy-1/1/2008
4National Cancer Institute-Frederick, Building 567, Room 203, Frederick, MD 21702John McCarthy-1/1/2008
3Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With FollicularJohn McCarthy-1/1/2008
2Key Statistics from Yahoo ... finance.yahoo.comJohn McCarthy-1/1/2008
1Accentia Biopharma to report positive data on three therapeutics in 1H08 DecembeJohn McCarthy-1/1/2008
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News